PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1621890
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1621890
Dog Dewormers Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032
The Global Dog Dewormers Market was valued at USD 1.4 billion in 2023 and is projected to expand at a 9.5% CAGR from 2024 to 2032. The surge in pet ownership, coupled with an increasing emphasis on preventing zoonotic diseases, is a major factor driving this market growth. The rising trend of pet ownership significantly influences market expansion. Changing lifestyles and urbanization are leading more individuals to seek companionship through pets, particularly dogs. Reports indicate that a substantial percentage of households in the U.S. own pets, reflecting a broader global trend where spending on veterinary care and pet products continues to rise.
As pet owners prioritize preventive measures to maintain pet health, the demand for effective deworming solutions is expected to grow. The dog dewormers market is categorized by product type into topical solutions, tablets & chewable treats, and injections. The tablets and chewable treats segment emerged as the highest revenue generator, bringing in approximately USD 768.6 million in 2023. This segment's popularity stems from its convenience and high compliance rates among pet owners, as flavored chewables are easier for dogs to ingest and are often accepted without fuss. Distribution channels for dog dewormers include veterinary clinics, retail pharmacies, online platforms, and pet stores.
The veterinary clinics segment generated the most revenue, totaling around USD 560.2 million in 2023. The expertise provided by veterinarians ensures that dewormers are tailored to meet each dog's specific needs. This professional guidance boosts pet owners' confidence in the products they choose, enhancing their perception of safety and efficacy. In North America, the dog dewormers market generated USD 513.3 million in revenue in 2023 and is anticipated to grow at a CAGR of 9.1% over the forecast period. This region, particularly the United States and Canada, boasts one of the highest pet ownership rates globally.
| Market Scope | |
|---|---|
| Start Year | 2023 |
| Forecast Year | 2024-2032 |
| Start Value | $1.4 Billion |
| Forecast Value | $3.1 Billion |
| CAGR | 9.5% |
The increasing number of pet-owning households fuels the demand for dog dewormers. Furthermore, there is a growing awareness of the significance of preventive healthcare for pets. As pet owners become more educated about the dangers of parasitic infections, they are more inclined to invest in regular deworming treatments to ensure their dogs remain healthy and parasite-free
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definition
- 1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
- 1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
- 1.4 Forecast model
- 1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources
Chapter 2 Executive Summary
- 2.1 Industry 360° synopsis
Chapter 3 Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increased pet ownership
- 3.2.1.2 Advancements in dewormer formulations
- 3.2.1.3 Increased focus on zoonotic diseases
- 3.2.1.4 Growing awareness about pet health
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 Regulatory challenges
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.4 Regulatory landscape
- 3.5 Technological landscape
- 3.6 Future market trends
- 3.7 Gap analysis
- 3.8 Porter's analysis
- 3.9 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
- 4.1 Introduction
- 4.2 Company matrix analysis
- 4.3 Competitive analysis of major market players
- 4.4 Competitive positioning matrix
- 4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)
- 5.1 Key trends
- 5.2 Tablets and chewable treats
- 5.3 Topical solutions
- 5.4 Injections
Chapter 6 Market Estimates and Forecast, By Distribution Channel, 2021 - 2032 ($ Mn)
- 6.1 Key trends
- 6.2 Veterinary clinics
- 6.3 Retail pharmacies
- 6.4 Online platforms
- 6.5 Pet stores
Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)
- 7.1 Key trends
- 7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Italy
- 7.3.5 Spain
- 7.3.6 Netherlands
- 7.3.7 Rest of the Europe
- 7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
- 7.4.6 Rest of Asia Pacific
- 7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
- 7.5.4 Rest of Latin America
- 7.6 Middle East and Africa
- 7.6.1 Saudi Arabia
- 7.6.2 South Africa
- 7.6.3 UAE
- 7.6.4 Rest of Middle East and Africa
Chapter 8 Company Profiles
- 8.1 Bayer AG
- 8.2 Beaphar
- 8.3 Bimeda, Inc.
- 8.4 Boehringer Ingelheim International GmbH
- 8.5 Ceva Sante Animale
- 8.6 Durvet Animal Health Products
- 8.7 Elanco Animal Health Incorporated
- 8.8 Jurox Pty Limited
- 8.9 Merck & Co., Inc.
- 8.10 Ourofino Animal Health
- 8.11 PetIQ, LLC.
- 8.12 Sava Healthcare Limited
- 8.13 Vetoquinol
- 8.14 Virbac SA
- 8.15 Zoetis Inc.
